Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | CES1 | P23141 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | KCNN4 | O15554 | 3/20 | 0.41 |
| ▸ | PGK1 | P00558 | 1/20 | 0.40 |
| ▸ | PGK2 | P07205 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL9562304 | 0.95 | CYP1A2 (0.50) | CYP1A2PTPN1ALDH1A1TSHRCES1 | |
| SCHEMBL29287593 | 0.84 | CYP1A2 (0.45) | CYP1A2PTPN1ALDH1A1TSHRCES1 | |
| SCHEMBL2429483 | 0.78 | CYP1A2 (0.48) | CYP1A2PTPN1ALDH1A1TSHRCES1 | |
| SCHEMBL4245525 | 0.78 | MAPT (0.56) | CYP1A2PTPN1ALDH1A1TSHRCES1 | |
| SCHEMBL522914 | 0.77 | CYP1A2 (0.52) | CYP1A2PTPN1ALDH1A1TSHRCES1 | |
| SCHEMBL354556 | 0.77 | CYP1A2 (0.52) | CYP1A2PTPN1ALDH1A1TSHRCES1 | |
| SCHEMBL14076371 | 0.76 | SRD5A2 (0.50) | CYP1A2ALDH1A1TSHRMAPTKMT2A | |
| Potassium Ion SCHEMBL5012104 | 0.76 | PTPN1 (0.45) | CYP1A2PTPN1ALDH1A1TSHRCES1 | |
| SCHEMBL3669362 | 0.75 | CYP1A2 (0.50) | CYP1A2PTPN1ALDH1A1TSHRCES1 | |
| SCHEMBL3629687 | 0.75 | CYP1A2 (0.50) | CYP1A2PTPN1ALDH1A1TSHRCES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101163699-A | Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof | MEDPOINTE HEALTHCARE INC (US) | 2008-04-16 | — | — | CN | disclosed |
| EP-1888570-A2 | METHODS FOR SYNTHESIS OF DICARBAMATE COMPOUNDS AND INTERMEDIATES IN THE FORMATION THEREOF | MedPointe Healthcare Inc. (US) | 2008-02-20 | — | — | EP | disclosed |
| WO-2006116007-A2 | METHODS FOR SYNTHESIS OF DICARBAMATE COMPOUNDS AND INTERMEDIATES IN THE FORMATION THEREOF | MEDPOINTE HEALTHCARE INC. (US) | 2006-11-02 | — | — | WO | disclosed |
| US-20060241298-A1 | Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof | MEDPOINTE HEALTHCARE INC. | 2006-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060241298-A1 | Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof | CPS1, ME1, TALDO1 | CYP1A2 2088/4885PTPN1 4487/4885ALDH1A1 460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.